Neurology Today

Neurology Today

Neurology Today serves as the official news platform for the American Academy of Neurology (AAN), providing timely updates on important news, developments, and trends in the field of neurology to an audience of over 20,000 professionals. This publication offers reliable, current, and insightful reporting and commentary tailored for the fast-paced lives of today's neurologists. Released bi-monthly, Neurology Today also grants readers exclusive access to essential information from the AAN, its official journal Neurology, and various other neurology-related publications.

International
English
Journal

Outlet metrics

Domain Authority
89
Ranking

Global

N/A

Country

N/A

Category

N/A

Traffic sources
Monthly visitors

Articles

  • 5 days ago | journals.lww.com | Catlin Nalley

    ​By Catlin NalleyThe Phase III SERENA-6 trial demonstrated that switching to camizestrant in combination with a CDK4/6 inhibitor—guided by the emergence of an ESR1 mutation (ESR1m) during first-line aromatase inhibitor plus CDK4/6 inhibitor therapy—led to a statistically significant and clinically meaningful improvement in progression-free survival (PFS) for patients with hormone receptor–positive, HER2-negative (HR+/HER2–) advanced breast cancer.

  • 2 months ago | journals.lww.com | Dawn Fallik

    ​Tolebrutinib, a brain-penetrant Bruton tyrosine (BTK) inhibitor, significantly slowed disability progression in multiple sclerosis, according to research from two different phase 3 trials presented at the AAN Annual Meeting in San Diego.

  • 2 months ago | journals.lww.com | Gina Shaw

    ​Use of over-the-counter (OTC) analgesics—including both acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs)—after a traumatic brain injury (TBI) was significantly associated with improved concussion symptoms and recovery, according to new data presented at the AAN Annual Meeting in San Diego. The prospective cohort study of National Collegiate Athletic Association (NCAA) and military cadets also found that the OTC drugs led to a quicker return to play.

  • 2 months ago | journals.lww.com | Gina Shaw

    Modern hormonal contraceptives, which contain substantially lower doses of estrogen compared with earlier-generation high-dose combined oral contraceptives, are not associated with an increased risk of stroke and other vascular events in women with migraine, both with and without aura, according to findings presented at the AAN Annual Meeting in San Diego. The large study used data from a nationwide de-identified electronic health record  database.

  • 2 months ago | journals.lww.com | Gina Shaw

    ​Inebilizumab (Uplizna), a monoclonal antibody targeting CD19+ B-cells, significantly improves disease severity in patients with generalized myasthenia gravis (MG), according to new findings from the MINT phase 3 clinical trial presented at the AAN Annual Meeting in San Diego.

Neurology Today journalists

Contact details

Address

123 Example Street

City, Country 12345

Phone

+1 (555) 123-4567

Email Patterns

Socials

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Traffic locations